GLPwatch
Trials (2036)
Page 3 of 34.
- Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
- The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
- A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
- Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- Weight Loss With Exenatide Treatment
- Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
- Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes
- Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
- Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
- A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
- A Study of LY3493269 in Participants With Type 2 Diabetes
- A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
- A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
- Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
- Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
- The Effect of Semaglutide on Bone Health
- A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
- Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
- A Study of SRSD384 in Overweight or Obese Participants
- A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
- Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
- Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
- Saxenda in Obesity Services (STRIVE Study)
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
- People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
- Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
- A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector
- Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
- Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
- Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
- Individualized Obesity Pharmacotherapy
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability
- GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
- Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
- GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
- To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants
- A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
- Evaluating Liraglutide in Alzheimer's Disease
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
- A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
- A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
- Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
- Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
- Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
- A Study of LY3502970 in Participants With Type 2 Diabetes
- Exenatide in Extreme Pediatric Obesity
- Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
- Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes